| Systematic reviews as a ‘lens of evidence’: determinants of benefits and harms of breast cancer screening O Mandrik, N Zielonke, F Meheus, JL Severens, N Guha, ... International journal of cancer 145 (4), 994-1006, 2019 | 69 | 2019 |
| Critical appraisal of systematic reviews with costs and cost-effectiveness outcomes: an ISPOR good practices task force report OL Mandrik, JLH Severens, A Bardach, S Ghabri, C Hamel, T Mathes, ... Value in Health 24 (4), 463-472, 2021 | 61 | 2021 |
| IARC perspective on oral cancer prevention V Bouvard, ST Nethan, D Singh, S Warnakulasuriya, R Mehrotra, ... New England Journal of Medicine 387 (21), 1999-2005, 2022 | 47 | 2022 |
| The costs and benefits of risk stratification for colorectal cancer screening based on phenotypic and genetic risk: a health economic analysis C Thomas, O Mandrik, CL Saunders, D Thompson, S Whyte, S Griffin, ... Cancer Prevention Research 14 (8), 811-822, 2021 | 30 | 2021 |
| Systematic reviews as a “lens of evidence”: determinants of participation in breast cancer screening O Mandrik, E Tolma, N Zielonke, F Meheus, C Ordóñez-Reyes, ... Journal of Medical Screening 28 (2), 70-79, 2021 | 25 | 2021 |
| Reviewing transferability in economic evaluations originating from Eastern Europe O Mandrik, S Knies, Z Kalo, JL Severens International journal of technology assessment in health care 31 (6), 434-441, 2015 | 21 | 2015 |
| The cost-effectiveness of belimumab and voclosporin for patients with lupus nephritis in the United States O Mandrik, J Fotheringham, S Ren, JA Tice, RH Chapman, MD Stevenson, ... Clinical Journal of the American Society of Nephrology 17 (3), 385-394, 2022 | 17 | 2022 |
| Disutility associated with cancer screening programs: a systematic review L Li, JL Severens, O Mandrik PloS one 14 (7), e0220148, 2019 | 17 | 2019 |
| Cognitions and behaviours of general practitioners in France regarding HPV vaccination: a theory-based systematic review G Escriva-Boulley, O Mandrik, M Préau, R Herrero, P Villain Preventive Medicine 143, 106323, 2021 | 16 | 2021 |
| Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges R Daubner-Bendes, S Kovács, M Niewada, M Huic, M Drummond, ... Frontiers in Public Health 8, 612410, 2021 | 16 | 2021 |
| Population preferences for breast cancer screening policies: Discrete choice experiment in Belarus O Mandrik, A Yaumenenka, R Herrero, MF Jonker PloS one 14 (11), e0224667, 2019 | 16 | 2019 |
| Impact of hypoglycemia on daily life of type 2 diabetes patients in Ukraine O Mandrik, JL Severens, O Doroshenko, V Pan’kiv, N Kravchun, ... Journal of Multidisciplinary Healthcare, 249-257, 2013 | 15 | 2013 |
| Systematic reviews as a “lens of evidence”: Determinants of cost‐effectiveness of breast cancer screening O Mandrik, OI Ekwunife, F Meheus, JL Severens, S Lhachimi, ... Cancer medicine 8 (18), 7846-7858, 2019 | 14 | 2019 |
| Effects of nutritional supplements on the re-infection rate of soil-transmitted helminths in school-age children: A systematic review and meta-analysis AUJ Isah, OI Ekwunife, IL Ejie, O Mandrik PLoS One 15 (8), e0237112, 2020 | 12 | 2020 |
| Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers: real‐world findings from NHS England between 2013 and 2019 JWF Catto, O Mandrik, LA Quayle, SA Hussain, J McGrath, J Cresswell, ... BJU international 131 (6), 734-744, 2023 | 11 | 2023 |
| Should colorectal cancer screening start at different ages for men and women? Cost‐effectiveness analysis for a resource‐constrained service C Thomas, O Mandrik, S Whyte, CL Saunders, SJ Griffin, JA Usher‐Smith Cancer Reports 4 (4), e1344, 2021 | 11 | 2021 |
| Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine O Mandrik, I Corro Ramos, S Knies, M Al, JL Severens Cancer management and research, 279-289, 2015 | 11 | 2015 |
| Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan O Mandrik, S Knies, JL Severens ClinicoEconomics and Outcomes Research, 347-356, 2015 | 10 | 2015 |
| Effectiveness of screening for oral cancer and oral potentially malignant disorders (OPMD): A systematic review U Parak, AL Carvalho, F Roitberg, O Mandrik Preventive Medicine Reports 30, 101987, 2022 | 9 | 2022 |
| Drug procurement policy in Ukraine: is there a window of opportunity? T Semigina, O Mandrik Вісник Академії праці, соціальних відносин і туризму, 25-38, 2017 | 9 | 2017 |
Zoltán KalóCenter for Health Technology Assessment, Semmelweis University; Syreon Res在 semmelweis.hu 的电子邮件经过验证
